192 related articles for article (PubMed ID: 38681125)
1.
Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
4.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
5. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
7. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
8.
Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
[TBL] [Abstract][Full Text] [Related]
9. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance.
Chen L; Zhao R; Kang Z; Cao Z; Liu N; Shen J; Wang C; Pan F; Zhou X; Liu Z; Yang Y; Chen Q
J Control Release; 2023 Nov; 363():43-56. PubMed ID: 37734673
[TBL] [Abstract][Full Text] [Related]
10. Fusobacterium nucleatum - Friend or foe?
Stokowa-Sołtys K; Wojtkowiak K; Jagiełło K
J Inorg Biochem; 2021 Nov; 224():111586. PubMed ID: 34425476
[TBL] [Abstract][Full Text] [Related]
11. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
[TBL] [Abstract][Full Text] [Related]
12.
Casasanta MA; Yoo CC; Udayasuryan B; Sanders BE; Umaña A; Zhang Y; Peng H; Duncan AJ; Wang Y; Li L; Verbridge SS; Slade DJ
Sci Signal; 2020 Jul; 13(641):. PubMed ID: 32694172
[No Abstract] [Full Text] [Related]
13. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade.
Wu Y; Wu J; Chen T; Li Q; Peng W; Li H; Tang X; Fu X
Dig Dis Sci; 2018 May; 63(5):1210-1218. PubMed ID: 29508166
[TBL] [Abstract][Full Text] [Related]
15. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
16.
Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
[TBL] [Abstract][Full Text] [Related]
17.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
18. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
[TBL] [Abstract][Full Text] [Related]
19.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
20. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
